Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Diabetes and Buildup of Tau May Be Linked

September 4, 2015 9:28 am | by Bevin Fletcher, Associate Editor, Bioscience Technology | News | Comments

People with type 2 diabetes may have a greater buildup of tangles of protein in their spinal fluid, irrespective of dementia, according to a new study published in Neurology. Read more...


Helsinn: Exclusive Agreement With Mundipharma for Distribution of Anamorelin

September 3, 2015 4:26 pm | News | Comments

Helsinn, the Swiss Group focused on building quality cancer care, and Mundipharma, today announce that they have entered into distribution, license and supply agreements granting exclusive rights to anamorelin in Switzerland and Liechtenstein. Read more...


Study Finds Increased Risk of MGUS in Vietnam Vets Exposed to Agent Orange

September 3, 2015 4:23 pm | News | Comments

A study that used stored blood samples from U.S. Air Force personnel who conducted aerial herbicide spray missions of Agent Orange during the Vietnam war found a more than 2-fold increased risk of the precursor to multiple myeloma known as monoclonal gammopathy of undetermined significance (MGUS), according to an article published online by JAMA Oncology. Read more...


Using Cell Phones to Track Disease Outbreaks

September 3, 2015 4:14 pm | by Greg Watry, Digital Reporter | News | Comments

Princeton and Harvard Univ. researchers have found mobile phone data can help predict seasonal disease patterns. Read more...


Aspirin Could Hold the Key to Supercharged Cancer Immunotherapy

September 3, 2015 4:11 pm | by Cancer Research UK | News | Comments

Giving cancer patients aspirin at the same time as immunotherapy could dramatically boost the effectiveness of the treatment, according to new research published in the journal Cell Thursday. Read more...


New Mechanism Discovered Behind Infant Epilepsy

September 3, 2015 4:04 pm | by Karolinska Institutet | News | Comments

Scientists at Karolinska Institutet and Karolinska University Hospital in Sweden have discovered a new explanation for severe early infant epilepsy. Mutations in the gene encoding the protein KCC2 can cause the disease, hereby confirming an earlier theory. The findings are being published in the journal Nature Communications. Read more...


Team Developing New Drug Against Leading Causes of Death — Sepsis and ARDS

September 3, 2015 3:58 pm | by Queen's University | News | Comments

Scientists at Queen's University Belfast are developing a potential revolutionary new treatment for Sepsis and Acute Respiratory Distress Syndrome (ARDS), which are among the leading causes of death in hospitalized patients in the UK. Read more...


Scientists Find Neuron Responsible for Alcoholism Craving

September 3, 2015 10:37 am | by Seth Augenstein, Digital Reporter | News | Comments

A particular neuron in the brain reaches out for the next drink – potentially functioning as a seat of alcoholism and other addictions, according to research by Texas A&M scientists. Alcohol alters neurons in the dorsomedial striatum, a part of the brain singled out to be important in goal-driven behavior, according to the study, published in the Journal of Neuroscience. Read more...


Hookah and E-Cigs Viewed as Safe by the Young

September 3, 2015 10:10 am | by Greg Watry, Digital Reporter | News | Comments

Researchers found young adults under 25 are more likely to rate hookah and e-cigarettes as safer. Read more...


Drug for Fungal Infections in Lung Transplant Recipients Increases Risk for Cancer, Death

September 3, 2015 9:54 am | by University of California, San Francisco | News | Comments

Voriconazole, a prescription drug commonly used to treat fungal infections in lung transplant recipients, significantly increases the risk for skin cancer and even death, according to a new study by UC San Francisco researchers. The team recommends physicians consider patient-specific factors that could modify the drug’s risks and benefits, when providing care. Read more...


Researchers Report Long-Term Remissions in First Personalized Cell Therapy Trial

September 3, 2015 9:50 am | by University of Pennsylvania School of Medicine | News | Comments

Eight of 14 patients in the first trial of the University of Pennsylvania's personalized cellular therapy for chronic lymphocytic leukemia (CLL) responded to the therapy, with some complete remissions continuing past four and a half years. Read more...


Legionnaires' Outbreaks Not Unusual in Summer & Early Fall

September 3, 2015 9:30 am | by Lindsay Tanner, AP Medical Writer | News | Comments

Legionnaires' disease has been reported in a handful of states this summer, leading to 19 deaths and more than 100 illnesses. The unrelated cases are part of a typical pattern seen with a disease that tends to appear in warm weather and is mostly dangerous for people who already are sick or weakened. Read more...


Scientists Move Closer to Curing Eye Disorder

September 3, 2015 8:15 am | by University of Manchester | News | Comments

Scientists have successfully restored the site of laboratory mice suffering from a common cause of blindness in people. Read more...


Ballooning Platelets and the Future of Anti-Thrombotic Drugs

September 3, 2015 8:00 am | by University of Bristol | News | Comments

Platelets play a central role in stopping bleeding (haemostasis) and causing blockages in arteries (arterial thrombosis), particularly in coronary artery disease. Read more...


Valeant Pharmaceuticals to Acquire Synergetics USA

September 3, 2015 7:45 am | News | Comments

The transaction is expected to close in the fourth quarter of 2015 and is subject to customary closing conditions and regulatory approvals. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.